MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$25,008K
EPS
-$0.63
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
License and development support revenue (including related party amounts of 0 and 251, respectively)
-
-
0
-
Research and development (including related party amounts of 13, 27, 26, and 50, respectively)
21,925
19,312
16,994
17,633
General and administrative
4,965
5,118
4,938
5,264
Total operating expenses
26,890
24,430
21,932
22,897
Loss from operations
-26,890
-24,430
-21,932
-22,897
Interest income
1,886
912
1,162
1,372
Change in fair value of safes (including related party amounts of 0 and 2,911, respectively)
-
-
0
-
Other (expense) income, net
-1
2
-2
-3
Total other income , net
1,885
914
1,160
1,369
Net loss
-25,005
-23,516
-20,772
-21,528
Unrealized (gain) loss on investments, net
-3
-121
16
85
Comprehensive loss
-25,008
-23,637
-20,756
-21,443
Basic EPS
-0.63
-0.95
-0.845
-0.88
Diluted EPS
-0.63
-0.95
-0.845
-0.88
Basic Average Shares
39,413,236
24,678,420
24,573,705
24,481,722
Diluted Average Shares
39,413,236
24,678,420
24,573,705
24,481,722
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$25,008K
(-17.67%↓ Y/Y)
Interest income
$1,886K
(20.82%↑ Y/Y)
Net loss
-$25,005K
(-17.65%↓ Y/Y)
Unrealized (gain) loss on
investments, net
-$3K
Total other income ,
net
$1,885K
(21.14%↑ Y/Y)
Other (expense)
income, net
-$1K
(80.00%↑ Y/Y)
Loss from operations
-$26,890K
(-17.89%↓ Y/Y)
Total operating
expenses
$26,890K
(17.89%↑ Y/Y)
Research and development
(including related party...
$21,925K
(22.75%↑ Y/Y)
General and
administrative
$4,965K
(0.32%↑ Y/Y)
Buy us a coffee
Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics, Inc. (ARTV)